{"id":"W2895782917","doi":"10.1016/j.breast.2018.10.001","title":"Targeting CDK4/6 pathways and beyond in breast cancer","year":2018,"lang":"en","type":"review","venue":"The Breast","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Palbociclib; Oncology; Metastatic breast cancer; Internal medicine; Fulvestrant; Breast cancer; Neutropenia; Cancer; Clinical trial; Disease; Adjuvant; Adjuvant therapy; Toxicity; Tamoxifen","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004774104,0.0008413718,0.00138,0.001663419,0.0002151516,0.001105848,0.0007856251,0.0009893229,0.007036577],"category_scores_gemma":[0.0009055475,0.0003368077,0.0005718136,0.001387321,0.0003687401,0.001304835,0.0007507309,0.002222704,0.002169495],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005391706,"about_ca_system_score_gemma":0.001146545,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001047655,"about_ca_topic_score_gemma":0.003486268,"domain_scores_codex":[0.9998448,0.00002514073,0.0000235474,0.00002693556,0.0000547692,0.00002463723],"domain_scores_gemma":[0.9997628,0.0001201132,0.00004121481,0.000006449719,0.000048185,0.00002120131],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001385858,0.00007259697,0.0001329673,0.02360731,0.0001502607,0.0001230214,0.00004643062,0.0003996062,0.001544402,0.0031696,0.04808308,0.9225321],"study_design_scores_gemma":[0.00006193827,0.000105653,0.0004619643,0.00469827,0.0002783648,0.0005431685,0.00003753934,0.0001057092,0.0004080278,0.001537289,0.9917457,0.00001638623],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008226949,0.9982827,0.00006909482,0.0002828781,0.0002037333,0.000005179606,0.00002772828,0.000006620049,0.001039808],"genre_scores_gemma":[0.000643347,0.9979842,0.0001053963,0.0003383721,0.0001301595,0.000006156618,0.00003889377,0.000001618768,0.0007518235],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.007036577,"threshold_uncertainty_score":0.02353966,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0316510750787628,"score_gpt":0.3233811829162637,"score_spread":0.2917301078375009,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}